title: TRPV1 receptor in expression of opioid-induced hyperalgesia.
abstract: Opiates are currently the mainstay for treatment of moderate to severe pain. However, prolonged administration of opiates has been reported to elicit hyperalgesia in animals, and examples of opiate-induced hyperalgesia have been reported in humans as well. Despite the potential clinical significance of such opiate-induced actions, the mechanisms of opiate-induced hypersensitivity remain unknown. The transient receptor potential vanilloid1 (TRPV1) receptor, a molecular sensor of noxious heat, acts as an integrator of multiple forms of noxious stimuli and plays an important role in the development of inflammation-induced hyperalgesia. Because animals treated with opiates show thermal hyperalgesia, we examined the possible role of TRPV1 receptors in the development of morphine-induced hyperalgesia using TRPV1 wild-type (WT) and knock-out (KO) mice and with administration of a TRPV1 antagonist in mice and rats. Administration of morphine by subcutaneous implantation of morphine pellets elicited both thermal and tactile hypersensitivity in TRPV1 WT mice but not in TRPV1 KO mice. Moreover, oral administration of a TRPV1 antagonist reversed both thermal and tactile hypersensitivity induced by sustained morphine administration in mice and rats. Immunohistochemical analyses indicate that sustained morphine administration modestly increases TRPV1 labeling in the dorsal root ganglia. In addition, sustained morphine increased flinching and plasma extravasation after peripheral stimulation with capsaicin, suggesting an increase in TRPV1 receptor function in the periphery in morphine-treated animals. Collectively, our data indicate that the TRPV1 receptor is an essential peripheral mechanism in expression of morphine-induced hyperalgesia.
  
  
  CONCLUSIONS
  Opioid-induced hyperalgesia possibly limits the usefulness of opioids, emphasizing the value of alternative methods of pain control. We demonstrate that TRPV1 channels play an important role in peripheral mechanisms of opioid-induced hyperalgesia. Such information may lead to the discovery of analgesics lacking such adaptations and improving treatment of chronic pain.
authors.affiliation: Department of Pharmacology, University of Arizona, Tucson, Arizona 85724, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Vardanyan
authors.forename: Ruizhong
authors.initials: R
authors.lastname: Wang
authors.forename: Todd W
authors.initials: TW
authors.lastname: Vanderah
authors.forename: Michael H
authors.initials: MH
authors.lastname: Ossipov
authors.forename: Josephine
authors.initials: J
authors.lastname: Lai
authors.forename: Frank
authors.initials: F
authors.lastname: Porreca
authors.forename: Tamara
authors.initials: T
authors.lastname: King
mesh_terms: D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D005727:Ganglia, Spinal / Q000378:metabolism; D006930:Hyperalgesia / Q000139:chemically induced / Q000378:metabolism* / Q000503:physiopathology*; D006941:Hyperesthesia / Q000378:metabolism / Q000503:physiopathology; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D010147:Pain Measurement / Q000379:methods; D017288:Pain Threshold / Q000187:drug effects* / Q000523:psychology; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014110:Touch / Q000187:drug effects
chemical_list: D000701:Analgesics, Opioid; D050916:TRPV Cation Channels; C493921:TRPV1 protein, mouse; D009020:Morphine
references.citation: J Neurosci. 2003 Sep 10;23(23):8370-9
references.pmid: 12967999
references.citation: Semin Cell Dev Biol. 2006 Oct;17(5):582-91
references.pmid: 17196854
references.citation: Neuroscience. 2003;121(3):815-24
references.pmid: 14568039
references.citation: Nature. 2000 May 11;405(6783):183-7
references.pmid: 10821274
references.citation: J Neurosci. 2000 Sep 15;20(18):7074-9
references.pmid: 10995854
references.citation: Pain. 2001 Feb 1;90(1-2):91-6
references.pmid: 11166974
references.citation: Neuroscience. 1996 Jan;70(1):201-9
references.pmid: 8848125
references.citation: Pflugers Arch. 2005 Oct;451(1):151-9
references.pmid: 15909179
references.citation: Neuron. 2002 Sep 26;36(1):57-68
references.pmid: 12367506
references.citation: Ugeskr Laeger. 1995 Jun 5;157(23):3307-10
references.pmid: 7543228
references.citation: Pain. 2005 Aug;116(3):276-288
references.pmid: 15964684
references.citation: Anesthesiology. 1986 Oct;65(4):449
references.pmid: 3767054
references.citation: Neurosci Lett. 1989 Jan 30;96(3):247-52
references.pmid: 2566136
references.citation: J Pain Symptom Manage. 2003 Aug;26(2):769-75
references.pmid: 12906962
references.citation: Pain. 1994 Nov;59(2):313-316
references.pmid: 7892029
references.citation: Neurosci Lett. 2006 Oct 23;407(2):156-61
references.pmid: 16959420
references.citation: J Neurosci. 2005 Jan 12;25(2):409-16
references.pmid: 15647484
references.citation: Pharmacol Biochem Behav. 1999 Feb;62(2):381-8
references.pmid: 9972707
references.citation: EMBO J. 2005 Dec 21;24(24):4211-23
references.pmid: 16319926
references.citation: J Neurosci. 2002 Aug 1;22(15):6773-80
references.pmid: 12151557
references.citation: Neuroscience. 1992 Aug;49(3):693-8
references.pmid: 1380138
references.citation: J Neurosci. 2001 Jun 1;21(11):4074-80
references.pmid: 11356895
references.citation: Pain. 1991 Dec;47(3):337-339
references.pmid: 1784504
references.citation: J Neurobiol. 2004 Oct;61(1):126-48
references.pmid: 15362157
references.citation: J Neurosci. 1994 Apr;14(4):2301-12
references.pmid: 7908958
references.citation: Pain. 1997 Aug;72(1-2):253-60
references.pmid: 9272810
references.citation: J Neurosci. 1996 Apr 1;16(7):2342-51
references.pmid: 8601814
references.citation: J Clin Psychiatry. 2002;63 Suppl 11:6-10
references.pmid: 12562137
references.citation: J Neurosci Methods. 1994 Jul;53(1):55-63
references.pmid: 7990513
references.citation: Neuroscience. 2000;99(3):529-39
references.pmid: 11029544
references.citation: J Neurosci. 2002 Aug 1;22(15):6747-55
references.pmid: 12151554
references.citation: Eur J Pharmacol. 1994 Feb 21;253(1-2):45-51
references.pmid: 8013548
references.citation: Science. 1999 Nov 19;286(5444):1558-61
references.pmid: 10567262
references.citation: J Pharmacol Exp Ther. 2003 Jan;304(1):56-62
references.pmid: 12490575
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7658-63
references.pmid: 10393876
references.citation: Pain. 2001 May;92(1-2):5-9
references.pmid: 11323121
references.citation: J Pharmacol Exp Ther. 2005 Apr;313(1):474-84
references.pmid: 15615864
references.citation: Pain. 1996 Sep;67(1):179-188
references.pmid: 8895246
references.citation: Nature. 1997 Oct 23;389(6653):816-24
references.pmid: 9349813
references.citation: Neuroscience. 2007 Mar 16;145(2):676-85
references.pmid: 17239544
references.citation: J Physiol. 2001 Aug 1;534(Pt 3):813-25
references.pmid: 11483711
references.citation: Regul Pept. 1993 Jul 2;46(1-2):150-4
references.pmid: 7692483
references.citation: Pain. 1988 Jan;32(1):77-88
references.pmid: 3340425
references.citation: Drug Alcohol Depend. 2001 Jul 1;63(2):139-46
references.pmid: 11376918
references.citation: Pain. 1995 Sep;62(3):259-274
references.pmid: 8657426
references.citation: Brain Res. 1987 Aug 18;418(1):201-3
references.pmid: 3664271
references.citation: J Neurosci. 2002 Oct 15;22(20):9086-98
references.pmid: 12388616
references.citation: Nat Rev Neurosci. 2001 Feb;2(2):83-91
references.pmid: 11252998
references.citation: J Neurosurg Anesthesiol. 1997 Apr;9(2):146-8
references.pmid: 9100184
references.citation: Am J Physiol Cell Physiol. 2004 Aug;287(2):C558-63
references.pmid: 15084474
references.citation: Ann Oncol. 2005 May;16 Suppl 4:iv132-135
references.pmid: 15923413
references.citation: Brain Res. 2002 Dec 20;958(1):28-35
references.pmid: 12468027
references.citation: J Neurophysiol. 1991 Jul;66(1):190-211
references.pmid: 1919666
references.citation: Anesthesiology. 2000 Feb;92(2):465-72
references.pmid: 10691234
references.citation: J Med Chem. 2004 May 20;47(11):2717-23
references.pmid: 15139748
references.citation: Eur J Pharmacol. 1990 Aug 10;184(2-3):207-12
references.pmid: 2150374
references.citation: Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2622-6
references.pmid: 7535928
references.citation: J Pharmacol Exp Ther. 1988 Feb;244(2):501-7
references.pmid: 3346833
references.citation: J Neurosci. 2001 Jan 1;21(1):279-86
references.pmid: 11150345
references.citation: Annu Rev Neurosci. 2001;24:487-517
references.pmid: 11283319
references.citation: Eur J Pharmacol. 1994 Sep 22;263(1-2):203-5
references.pmid: 7821354
references.citation: Anesthesiology. 1986 May;64(5):590-7
references.pmid: 2938524
references.citation: Br J Pharmacol. 2000 Nov;131(5):875-84
references.pmid: 11053206
references.citation: Proc Natl Acad Sci U S A. 1988 Jan;85(2):622-6
references.pmid: 2893375
references.citation: Science. 2000 Apr 14;288(5464):306-13
references.pmid: 10764638
references.citation: Annu Rev Pharmacol Toxicol. 1980;20:441-62
references.pmid: 7387124
references.citation: J Pharmacol Exp Ther. 2002 Jan;300(1):265-72
references.pmid: 11752125
references.citation: J Neurosci. 1997 Oct 15;17(20):8049-60
references.pmid: 9315923
references.citation: Eur J Neurosci. 2001 Jun;13(11):2105-14
references.pmid: 11422451
references.citation: J Pharmacol Exp Ther. 2003 Jul;306(1):387-93
references.pmid: 12721336
references.citation: Neurosci Lett. 1998 Jul 10;250(3):193-6
references.pmid: 9708865
references.citation: Science. 1997 Oct 10;278(5336):275-9
references.pmid: 9323204
references.citation: J Pharmacol Exp Ther. 1985 Nov;235(2):282-6
references.pmid: 4057070
references.citation: J Neurophysiol. 2006 May;95(5):3086-96
references.pmid: 16467418
references.citation: Neuroscience. 1998 May;84(2):583-9
references.pmid: 9539228
references.citation: Pain. 1993 Oct;55(1):93-97
references.pmid: 8278214